Project Details
Description
four pages) ............. 6-8
Other Biographical Sketches (Not to exceed four pages for each) ............................................... 9-31
Resources ...................................................................................................................................... 32
Research Plan
33-35
Introductionto Revised Application (Not to exceed 3 pages) ...............................................................................................................................
Introduction to Supplemental Application (Notto exceed one page) ....................................................................................................................
A. Specific Aims .......................................................................... _ .........................................................................................................
36-60
B. Background and Significance ...................................................... !...................................................................................................... _._"
C. Preliminary Studies/Progress Report/ _ (Items A-D: not to exceed 25 pages*) _K_
Phase I Progress Report (SBIPJSTTR Phase II ONLY) I * SBIR/STTR Phase I: Items A-D limited to 15 pages, t
D. Research Design and Methods ............................................ _ .....................................................................................................
E Human Subjects .........................................................................................................................................................................................
Protection of Human Subjects (Required if Item 4 on the Face Page is marked "Yes")
Inclusion of Women (Required if Item 4 on the Face Page is marked "Yes") ...................................................................................
Inclusion of Minorities (Required if Item 4 on the Face Page is marked "Yes") ................................................................................
Inclusion of Children (Required if Item 4 on the Face Page is marked "Yes") ...................................................................................
Data and Safety Monitoring Plan (Required if Item 4 on the Face Page is marked "Yes" anda Phase I, 11,or III clinical roposed
trial is proposed ................................................................................................................................................................................
F. Vertebrate Animals ..................................................................................................................................................................................... 61
G, Literature Cited ...........................................................................................................................................................................................
H. Consortium/Contractual Arrangements ....................................................................................................................................................
I. Consultants ................................................................................................................................................................................................. 68-74
J. Product Development Plan (SBIR/STTR Phase I1and Fast-Track ONLY) ...........................................................................................
Checklist ........................................................................................................................................ 75
Check if
Appendix (Five collated sets_ No page numbering necessary for Appendix.)
Appendix is
Included
Appendices NOT PERMITTED for Phase I SBIR/S TTR unless specifically solicited,
6
Number of publications and manuscripts accepted for publication (not to exceed 10)
Other items (list):
PHS 398 (Rev, 510 l) Page 3
Number pages consecutively at the bottom throughout the application. Do _t use suffixes such as 3a, 3b,
Status | Finished |
---|---|
Effective start/end date | 4/1/99 → 1/31/09 |
Funding
- National Institute of Allergy and Infectious Diseases: $388,750.00
- National Institute of Allergy and Infectious Diseases: $388,750.00
- National Institute of Allergy and Infectious Diseases: $231,089.00
- National Institute of Allergy and Infectious Diseases: $379,614.00
- National Institute of Allergy and Infectious Diseases: $224,360.00
- National Institute of Allergy and Infectious Diseases: $194,375.00
- National Institute of Allergy and Infectious Diseases: $368,605.00
ASJC
- Genetics
- Molecular Biology
- Virology
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.